January 27, 2023 Experience Pacific Biosciences $201.25 million follow-on offering The shares are listed on the Nasdaq Global Select Market
January 27, 2023 Experience Precigen $75 million follow-on offering We advised Precigen on the SEC-registered offering
January 25, 2023 Experience Deciphera Pharmaceuticals $135.1 million common stock offering The common stock is listed on the Nasdaq Global Select Market
January 20, 2023 Experience iQIYI $442 million follow-on offering We advised the issuer on a follow-on offering of ADSs
January 18, 2023 Experience New Horizon Health HK$781.7 million top-up placement of shares We advised New Horizon Health on the top-up placement
January 18, 2023 Experience Jinxin Fertility Group HK$1.17 billion top-up placement of shares The shares are listed on the Hong Kong Stock Exchange
January 18, 2023 Experience Expro $151.8 million secondary offering The shares are listed on the NYSE
January 13, 2023 Experience Cactus $172.5 million follow-on offering We advised Cactus on the stock offering
January 12, 2023 Experience Bilibili convertible notes exchange and concurrent follow-on equity offering The transaction involved a convertible notes exchange and a concurrent follow-on offering of ADSs
January 3, 2023 Experience Tellurian $500 million at-the-market offering The shares are listed on the NYSE